🚚 Free Tracked 24 on all pens · other orders free over £50, otherwise £5.99 🖊️ Peptide Pens → 🖊️ Retatrutide Pens: 20mg £124.99 · 40mg £159.99 → 🎬 View Peptide Videos → 🔬 New: Senolytics & Longevity Research. Explore the science → 👤 Members save 10% on eligible products. Join free → 🚚 Free Tracked 24 on all pens · other orders free over £50, otherwise £5.99 🖊️ Peptide Pens → 🖊️ Retatrutide Pens: 20mg £124.99 · 40mg £159.99 → 🎬 View Peptide Videos → 🔬 New: Senolytics & Longevity Research. Explore the science → 👤 Members save 10% on eligible products. Join free → 🚚 Free Tracked 24 on all pens · other orders free over £50, otherwise £5.99 🖊️ Peptide Pens → 🖊️ Retatrutide Pens: 20mg £124.99 · 40mg £159.99 → 🎬 View Peptide Videos → 🔬 New: Senolytics & Longevity Research. Explore the science → 👤 Members save 10% on eligible products. Join free →

CJC-1295 (DAC-free)

For In-Vitro Laboratory Research Use Only • Not for Human or Veterinary Use

CJC-1295 (DAC-free) Peptide

CJC-1295 no DAC (also written CJC1295) is the 29-amino-acid peptide often called Mod GRF (1-29). We do not list the DAC form.

Which form is listed here? This listing is for the DAC-free peptide, commonly called modified GRF (1-29). DAC means Drug Affinity Complex. The DAC-free material and the DAC-bearing form described as CJC-1295 in the literature are not interchangeable names for the same chemical structure. Match the exact form and batch documentation, not just the shortened name.

For laboratory research use only. Not for human or veterinary use.

£15.99 – £39.99 / vialFrom £13.59 / vial (15% Multi-Vial Savings)

🧪 MULTI-VIAL RESEARCH SAVINGS Buy 2 Save 10% · Buy 3+ Save 15%
1 Vial Standard £15.99 / vial
Buy 2 Vials Save 10% £14.39 / vial
Buy 3+ Vials Save 15% £13.59 / vial
Mix & match vials — 10% off 2 vials and 15% off 3+ vials auto-applies in your basket + Free Tracked 24 on all pens · other orders free over £50, otherwise £5.99.
💧 Reconstitution Bundle: add 10ml Bacteriostatic Water (£5.99) with any lyophilised peptide — FREE on orders over £100.
💧 + Add 10ml BAC Water (£5.99 / Free £100+)
Ways to pay. You place the order first, then pay by a secure payment link (all major credit and debit cards including Visa, Mastercard and American Express, Apple Pay, Google Pay, PayPal including Pay in 3, or a Zilch virtual card) or by UK bank transfer.

FOR IN-VITRO LABORATORY RESEARCH USE ONLY — NOT FOR HUMAN OR VETERINARY USE

These products are research chemicals. They are not medicines, food, or supplements. They have not been evaluated by the MHRA, FDA, or any other regulatory body. Not intended to diagnose, treat, cure, or prevent any disease. All descriptions are for reference and research documentation purposes only. By purchasing, you confirm you are aged 18+ and using these products exclusively for in vitro laboratory research.

About CJC-1295 (DAC-free)

CJC-1295 (DAC-free), also known as modified GRF (1-29), is a synthetic analogue of the first 29 amino acids of growth hormone-releasing hormone (GHRH), the region that carries the full biological activity of the hormone [2]. Four amino acids are substituted (D-Ala at position 2, Gln at 8, Ala at 15 and Leu at 27) to make it more resistant to breakdown, and the C-terminus is amidated [1, 2]. It has the sequence Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2.

The original CJC-1295 described in the scientific literature also carries a “drug affinity complex” (DAC): an extra lysine with a maleimidopropionyl group that binds covalently to serum albumin and greatly extends its half-life [1]. The product sold here does not contain the DAC. CJC-1295 has not been approved as a medicine by the MHRA, the FDA or any other regulator, and the product sold here is a research compound for laboratory use only.

Related research compound: Ipamorelin, a synthetic pentapeptide that acts at the ghrelin (growth hormone secretagogue) receptor and not at the GHRH receptor.

Areas of research

Most published research concerns CJC-1295 with DAC, and dedicated studies of the DAC-free form are limited. Published work includes:

  • the design of albumin-binding derivatives of GRF(1-29), and their stability and activity in rat pituitary cell assays and in rats [1]
  • pharmacokinetic and pharmacodynamic studies of CJC-1295 with DAC in healthy adult volunteers [2, 3]
  • studies of growth parameters in mice lacking the GHRH gene [4]

Findings on the DAC version cannot be assumed to apply to the DAC-free form, which lacks the albumin-binding group. The evidence base remains at an early stage.

Product specifications

Form Lyophilised (freeze-dried) powder in a sealed vial
Sizes 2mg, 5mg, 10mg
Sequence 29 amino acids, C-terminal amide (modified GRF 1-29), without DAC
Molecular formula C152H252N44O42 (calculated from sequence)
Molecular weight approx. 3368 g/mol (calculated from sequence)
Purity COA shown is for the 5mg batch. The current 5mg COA reports HPLC purity of >99.6%.

Storage and handling

Storage & Handling — Corex Vitality™ research vials

  • As supplied: freeze-dried (lyophilised) powder in a sealed vial. Room-temperature transit is normal for dry peptides.
  • Longer storage: keep the vial tightly closed in a freezer at −20 °C or colder, dry and away from light. Colder is better for long archives.
  • Short-term: a laboratory fridge (2–8 °C) is fine for vials you plan to open soon.
  • Before opening: let the closed vial warm to room temperature, ideally in a desiccator, so moisture does not condense on the powder. Work quickly and reseal tightly; absorbed moisture lowers the real peptide content.
  • Dissolving: choose a solvent based on the sequence (see the compound note below) and test a small portion first. Swirl gently; brief sonication in a water bath can help. Do not heat.
  • Once in solution: make up only what you need. Split any solution you keep into single-use aliquots, freeze at −20 °C or colder and thaw each aliquot only once. Peptides keep far less well in solution than as dry powder.
  • Safety: handle in a suitable laboratory with appropriate PPE, following your institution’s safety procedures, and avoid breathing the powder. Keep out of reach of children.

Compound note: No Cys, Met or Trp, but three glutamines, so it keeps less well in solution — aliquot and freeze promptly. Basic: a trace of dilute acetic acid before dilution if slow.

For in-vitro laboratory research use only. Not for human or veterinary use. General guidance paraphrased from Bachem: Handling and Storage Guidelines for Peptides and Peptide Solubility.

Quality and testing

CJC-1295 (DAC-free) batches we sell have a published third-party HPLC Certificate of Analysis. On Lingda reports the Client is the manufacturer/supplier; we publish the file exactly as issued. The COA shown is for the 5mg batch; no separate COA has been issued for the 2mg or 10mg sizes. You can also browse every published certificate on our COA and verification page.

CJC-1295 naming questions

Does DAC-free mean the same chemical form as CJC-1295 with DAC?

No. The DAC-bearing form includes an additional chemical group that is absent from the DAC-free material. A paper or certificate should identify which form it describes; findings and specifications for one form should not be assigned to the other automatically.

Does a purity percentage confirm the listed peptide sequence?

No. Purity and identity are separate analytical questions. Check which tests the batch certificate actually reports on our verification page. The CJC-1295 video page is an introduction, not a substitute for batch records.

Research use only

For in-vitro laboratory research use only. Not for human or veterinary use. These products are research chemicals. They are not medicines, food, or supplements. They have not been evaluated by the MHRA, FDA, or any other regulatory body. Not intended to diagnose, treat, cure, or prevent any disease. All descriptions are for reference and research documentation purposes only. By purchasing, you confirm you are aged 18+ and using these products exclusively for in vitro laboratory research.

Related reading

References

  1. Jetté L, et al. Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Endocrinology. 2005. PubMed 15817669
  2. Teichman SL, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006. PubMed 16352683
  3. Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab. 2006. PubMed 17018654
  4. Alba M, et al. Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse. Am J Physiol Endocrinol Metab. 2006. PubMed 16822960

Additional information

Size

2mg, 5mg, 10mg

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Cover of the free guide: How to read a COA

Free guide

How to read a COA

Get it by email, plus our research updates. No spam, unsubscribe any time.

We will email you to confirm first, then send the guide. We use your name and email only to send you these emails. Privacy policy. For laboratory research use only.

Listed on PepmarketVerified on PeptideReview
🎬 Scientific Explainer Video · What It Is For & How It Works

CJC-1295 (Without DAC / Mod-GRF 1-29) — Laboratory Mechanism & Research Overview

⬇ Download Video (MP4) All Peptide Videos →
🔬 What Is This Peptide Researched For?
  • Studying physiological, short-half-life (~30 min) GHRH receptor activation and pulsatile signalling
  • Examining four amino-acid substitutions (positions 2, 8, 15, 27) that prevent DPP-4 cleavage and oxidation
  • Investigating cAMP + Ca2+ synergy when co-administered with selective GHS-R1a agonists (Ipamorelin)
⚙️ How Does It Work? (Mechanism of Action)
1. Pituitary GHRH-R Engagement: Binds the G-protein-coupled Growth Hormone Releasing Hormone receptor on somatotrophs.
2. Gs / Adenylyl Cyclase / cAMP Pathway: Elevates intracellular cAMP and activates Protein Kinase A (PKA) transcription & synthesis.
3. Physiological Pulse Preservation: Produces a clean ~30-minute signalling pulse without continuous albumin-bound trough elevation.
📚 Peer-Reviewed Literature · PubMed Indexed

Published Research — Peer-Reviewed Receptor & Pathway Studies

NCBI PubMed Database ↗ Verify Batch COAs →

CJC-1295 (DAC-Free / Mod GRF 1-29)

  1. [1] Theriault Y et al. · Biopolymers (1988)

    Two-dimensional 1H-NMR spectroscopy and distance-geometry structural determination of the biologically active 29-amino-acid N-terminal domain of growth hormone-releasing factor, identifying two α-helical regions.

    PMID: 3149201 ↗ DOI: 10.1002/bip.360271204 ↗
  2. [2] Stepień T et al. · Neuropeptides (2009)

    In-vitro cell culture study demonstrating specific GHRH(1-29)-NH2 receptor binding, cellular proliferation, and vascular endothelial growth factor (VEGF) secretion in neuroendocrine cell lines.

    PMID: 19747727 ↗ DOI: 10.1016/j.npep.2009.08.005 ↗
  3. [3] Memdouh S et al. · Drug Test Anal (2021)

    Analytical review of synthetic GHRH(1-29) analogues including CJC-1295 and sermorelin, covering solid-phase sequence modifications, proteolytic cleavage pathways, and high-resolution mass spectrometry identification.

    PMID: 34665524 ↗ DOI: 10.1002/dta.3183 ↗
  4. [4] Uçaktürk E et al. · J Pharm Biomed Anal (2026)

    Validation of a nano-LC–quadrupole/Orbitrap high-resolution mass spectrometry workflow for separating and quantifying intact GHRH(1-29) analogues and their N-terminal enzymatic fragments.

    PMID: 41138283 ↗ DOI: 10.1016/j.jpba.2025.117207 ↗

Ipamorelin (Selective GHSR-1a Pentapeptide)

  1. [1] Raun K et al. · Eur J Endocrinol (1998)

    Foundational receptor-pharmacology characterisation of the synthetic pentapeptide ipamorelin (Aib-His-D-2-Nal-D-Phe-Lys-NH2) in primary rat pituitary cells and in-vivo models, demonstrating high GHSR-1a selectivity without ACTH or cortisol elevation.

    PMID: 9849822 ↗ DOI: 10.1530/eje.0.1390552 ↗
  2. [2] Ankersen M et al. · J Med Chem (1998)

    Medicinal chemistry and structure-activity relationship study of ipamorelin pentapeptide analogues evaluating N-methylated backbones and aromatic side-chain conformations in rat pituitary cell assays.

    PMID: 9733495 ↗ DOI: 10.1021/jm9801962 ↗
  3. [3] Johansen PB et al. · Growth Horm IGF Res (1999)

    Pre-clinical rodent study quantifying concentration-dependent longitudinal bone growth rate and somatotroph hormone release following administration of the selective pentapeptide secretagogue ipamorelin.

    PMID: 10373343 ↗ DOI: 10.1054/ghir.1999.9998 ↗
  4. [4] Svensson J et al. · J Endocrinol (2000)

    Dual-energy X-ray absorptiometry (DXA) and peripheral quantitative computed tomography (pQCT) study in rodent models examining cortical and cancellous bone mineral content under GHSR-1a agonist stimulation.

    PMID: 10828840 ↗ DOI: 10.1677/joe.0.1650569 ↗

References are provided for scientific context only. All Corex Vitality™ compounds are supplied strictly for in-vitro laboratory research use (RUO).